Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,221 | 22,317 | 11,644 | 17,552 | 21,181 |
| Receivables | 241 | 264 | 196 | 177 | 235 |
| TOTAL | $17,600 | $23,111 | $12,668 | $18,912 | $22,711 |
| Non-Current Assets | |||||
| PPE Net | 127 | 143 | 174 | 192 | 222 |
| Intangibles | 0 | 0 | 0 | 123 | 140 |
| TOTAL | $127 | $143 | $174 | $315 | $363 |
| Total Assets | $17,727 | $23,254 | $12,842 | $19,227 | $23,074 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,374 | 5,092 | 5,071 | 6,892 | 6,563 |
| Other current liabilities | N/A | N/A | 3 | 991 | 1,517 |
| TOTAL | $5,398 | $5,116 | $5,097 | $7,898 | $8,092 |
| Non-Current Liabilities | |||||
| TOTAL | $81 | $92 | $98 | $104 | $112 |
| Total Liabilities | $5,479 | $5,207 | $5,196 | $8,002 | $8,204 |
| Shareholders' Equity | |||||
| Common Shares | 124,889 | 130,879 | 113,345 | 111,322 | 112,004 |
| Retained earnings | -130,604 | -130,820 | -125,856 | -115,704 | -112,497 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 2,608 |
| TOTAL | $12,248 | $18,047 | $7,646 | $11,224 | $14,870 |
| Total Liabilities And Equity | $17,727 | $23,254 | $12,842 | $19,227 | $23,074 |